Search - tctmd.com

Presenter: Ronald Caputo, Martin Leon, Patrick Serruys, Franz-Josef Neumann, Alan Yeung, Stephan Windecker, Jorge Belardi, Sigmund Silber, Ian Meredith, Petr Widimsky, Shigeru Saito, Laura Mauri

January 31, 2013

Presentation TCT 2013

Primary Results Following Percutaneous Coronary Intervention with the 38 mm Resolute Zotarolimus-eluting Stent

Presenter: Shirish Hiremath, Robaayah Zambahari, Martin Leon, Laura Mauri, Alan Yeung, Michael Lee

January 31, 2013

Presentation TCT 2013

Final Three Year Results Following Resolute Zotarolimus-eluting Stent Implantation in the RESOLUTE International Trial

Presenter: Franz-Josef Neumann, Petr Widimsky, Jorge Belardi

January 31, 2013

News Daily News

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Caitlin E. Cox

December 26, 2012

News Daily News

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Caitlin E. Cox

December 26, 2012

Presentation

Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V vs. Zotarolimus-Eluting Resolute Stents in Real-World Practice

Presenter: K. W. Park

December 25, 2012

News Daily News

ZEN Published: Pelvic Artery Stenting Helps Treat Erectile Dysfunction in Some

November 27, 2012

News Daily News

ZEN Publicó: Colocación de stent en la arteria pélvica ayuda a tratar la disfunción eréctil en algunos pacientes

November 27, 2012

News Conference News TCT 2012

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

October 24, 2012

News Conference News TCT 2012

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

October 24, 2012

Presentation TCT 2012

TCT-47. Two-year Clinical Outcome of the TWENTE Trial, A Randomized Controlled Trial Comparing Second-generation Zotarolimus-eluting Resolute Stents vs. Everolimus-eluting...

Presenter: Clemens von Birgelen

October 23, 2012

News Industry News

Medtronic Stent Successfully Treats Long Lesions and Small Vessels, Two Characteristics Typical of Patients with Diabetes, in Multiple Studies

October 23, 2012

Presentation TCT 2012

RESOLUTE All-Comers at Three Years

Presenter: Sigmund Silber

October 22, 2012

News Conference News TCT 2012

Several Trials Highlight DES Comparisons

October 22, 2012

Advertisement

Conversations in Cardiology: Brief Question re: BMS-DES and DAPT

ACC/i2 2013: Controversy, Late Breaking Trial News Dominate Busy Meeting

With Medtronic Resolute Stent, Interrupting Dual Antiplatelet Therapy After One Month Showed No Increased Safety Risk in Robust Analysis

Pair of Studies Show Positive Stent Results at ACC

Medtronic Approved to Update Resolute Integrity Stent’s ‘CE’ Mark Labeling on Dual Antiplatelet Therapy

FDA Approves Longer Lengths of Medtronic’s Resolute Integrity Stent

Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ?2.5 mm Diameter

Primary Results Following Percutaneous Coronary Intervention with the 38 mm Resolute Zotarolimus-eluting Stent

Final Three Year Results Following Resolute Zotarolimus-eluting Stent Implantation in the RESOLUTE International Trial

Real-World Equivalence Seen for Zotarolimus- and Everolimus-Eluting Stents

Equivalencia en el Mundo Real Confirmada de los Stents liberadores de Zotarolimus y Everolimus

Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V vs. Zotarolimus-Eluting Resolute Stents in Real-World Practice

ZEN Published: Pelvic Artery Stenting Helps Treat Erectile Dysfunction in Some

ZEN Publicó: Colocación de stent en la arteria pélvica ayuda a tratar la disfunción eréctil en algunos pacientes

Positive Long-Term Results from LEADERS, BioFreedom FIM, ISAR-TEST 5

ISAR-LEFT MAIN 2: Second-Generation DES Effective in Left Main CAD

TCT-47. Two-year Clinical Outcome of the TWENTE Trial, A Randomized Controlled Trial Comparing Second-generation Zotarolimus-eluting Resolute Stents vs. Everolimus-eluting...

Medtronic Stent Successfully Treats Long Lesions and Small Vessels, Two Characteristics Typical of Patients with Diabetes, in Multiple Studies

RESOLUTE All-Comers at Three Years

Several Trials Highlight DES Comparisons

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content